Understanding MAL and NOT Numbers in Malaysia

Introduction

MAL and NOT identify different regulatory pathways. MAL concerns registered medicinal products, including relevant traditional products, whereas NOT identifies notified cosmetics. They are not interchangeable. This topic matters because regulatory requirements should be considered before manufacturing and marketing. Suitable evidence, records and responsibilities vary with the product category and its claims. This is a general educational guide for entrepreneurs planning an OEM project in Malaysia; it does not certify that any particular product qualifies for registration or notification.

Start with the correct classification

Before making commercial decisions, establish whether the proposed product is a registered medicine, natural product, over-the-counter medicine or notified cosmetic. Classification is not determined solely by a marketing name or package format. Ingredients, intended function, method of use and label or advertising claims must be considered together. Where a case is unclear, seek classification guidance through an appropriate NPRA channel. An early mistake may require expensive changes to the formula, positioning and packaging artwork.

Review ingredients and claims

Prepare a complete ingredient list with functions, scientific names where relevant, use levels and sources. Proposed claims must be consistent with the applicable product category and the available supporting evidence. Cosmetic labels should not casually claim to treat, cure or prevent disease. Medicinal and natural products are subject to their own permitted claim frameworks. Reviewing the formula and the label together is particularly useful because an attractive promotional phrase may conflict with the technical dossier.

Define brand-owner and manufacturer roles

The brand owner should agree who is responsible for formula specifications, prototypes, manufacturing, raw-material purchases, tests, change control and record retention. An OEM manufacturer can supply technical documentation within its agreed service scope. Nevertheless, the registration or notification holder must understand its own regulatory obligations. Written arrangements should cover label approvals, complaint handling, traceability and the escalation route for technical questions before the product is launched.

Build a controlled quality dossier

Maintain a development file covering composition, raw-material specifications, finished-product criteria, packaging information, draft labels and relevant quality evidence. The necessary studies, certificates and laboratory reports differ across product categories. Version control matters when the formula, supplier or packaging changes. Information submitted to the authority should be traceable to controlled source documents rather than copied only from promotional artwork or a salesperson’s description.

Plan an organised application

After confirming the category, arrange evidence against the relevant checklist and use the official submission channel, including QUEST3+ where applicable. Assign someone to manage the account, receive regulatory queries and coordinate technical responses with the document owners. A well-prepared submission can reduce avoidable rework, but it cannot guarantee approval. Requests for clarification should be answered using supporting records checked by the relevant technical and regulatory personnel.

Avoid predictable mistakes

Common problems include finalising artwork before classification, making overly broad claims, using inconsistent ingredient names and submitting tests that do not address the required specifications. Some entrepreneurs also assume that a NOT number is equivalent to medicinal approval or that an OEM supplier can promise a favourable decision. Neither assumption is sound. A cross-functional review involving formulation, quality, marketing and regulatory teams should be completed before final artwork is released.

Maintain compliance after launch

Regulatory responsibilities continue after a product reaches the market. Changes to formulas, suppliers, manufacturing sites, labels and claims must be assessed, with follow-up determined by the product category and nature of the change. Complaints, safety information and relevant renewal or update obligations also require attention. Effective change control improves communication between the brand owner and OEM manufacturer and reduces the chance of outdated labels being used in a subsequent production run.

A practical starting point

Write a one-page product brief describing the target customer, intended function, proposed ingredients, dosage or presentation, marketing claims and launch objectives. Discuss this brief with an OEM manufacturer and suitable regulatory adviser before ordering substantial packaging quantities. Sari Tani Desa can discuss formulation development, manufacturing and documentation support within an agreed project scope. Formal regulatory assessment and the eventual decision remain with the relevant authority.